Burkina Faso

in page functions
[French]
Total population (2016) 18,633,721
Birth cohort (2016) 729,426
Surviving Infants (surviving to 1 year per year, 2016) 685,266
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 61/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 89/1000
World Bank Index, IDA (2012) 3.78
Co-financing status (2016) Initial self-financing
No. of districts/territories (2014) 63

Gavi support for Burkina Faso

Type of support

Approvals

2001-2020 (US$)
(30 Apr 2016)

Commitments

2001-2020 (US$)
(30 Apr 2016)

Disbursements

2000-2016 (US$)
(30 Apr 2016)

% Disbursed

(30 Apr 2016)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Cash Support (CASHSUPP) $145,000 $170,000 $145,000 100%
Health system strengthening (HSS 1) $4,978,500 $4,978,500 $4,978,500 100%
Health system strengthening (HSS 2) $3,077,247 $4,511,558 $3,077,247 100%
HPV Demo (NVS) $191,000 $191,000 $192,376 101%
Immunisation services support (ISS) $9,768,940 $9,768,940 $9,768,940 100%
Injection safety support (INS) $931,560 $931,560 $931,560 100%
IPV (NVS) $1,425,515 $2,351,515 $672,923 47%
Measles (NVS) $597,150 $597,150 $469,902 79%
Measles-Rubella (NVS) $6,000,965 $6,000,965 $6,000,965 100%
Meningitis A (NVS) $574,000 $1,996,500
MR - Operational costs (OPC) $5,183,000 $5,183,000 $5,183,000 100%
Penta (NVS) $60,914,052 $60,914,052 $61,445,693 101%
Pneumo (NVS) $38,758,013 $38,758,013 $40,021,108 103%
Rotavirus (NVS) $28,206,298 $28,206,298 $26,948,533 96%
Vaccine Introduction Grant (VIG) $3,676,889 $3,676,889 $3,079,000 84%
Total $164,428,128 $168,235,939 $162,914,746

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Burkina Faso DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2014)

Grade of confidence


N/A
DTP3 - Official country estimates (2014) 91%
M:F sex ratio at birth (2016) 1.05
Household survey: DTP3 coverage for male (2009) 90.30%
Household survey: DTP3 coverage for female (2009) 88.80%
Household survey: Last DTP3 survey (2009) 90%
% districts achieving > 80% DTP3 coverage (2014) 100%
% districts achieving < 50% DTP3 coverage (2014) 0%
MCV WHO/UNICEF estimates (2014) 88%

Breakdown of support

Non-vaccine support Vaccine support
16% 84%
$25,949,247 $135,751,495

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Burkina Faso

22 February 2016

Gavi item

Meningitis A nearly eliminated in Africa through vaccination

Joint press release first published by WHO and PATH, joint founders of the Meningitis Vaccine Project.

10 November 2015

Gavi item

Scientists mark 'stunning success' of vaccine in virtually ridding Africa of meningitis A

New research forecasts a resurgence of meningitis A epidemics in 15 years should immunization efforts stall.

25 June 2015

Dr Seth Berkley, CEO of Gavi; Bill Gates Co-Chair of the Bill & Melinda Gates, Laurent Fabius, Minister of Foreign Affairs and International Development, Jean-Marc Gravellini, Executive Director in charge of Operations of the AFD.

Health in the Sahel region, together to improve immunisation programmes

The AFD, the Bill and Melinda Gates Foundation and Gavi signed an Initiative to increase coverage rates in six Sahel countries.

close icon

modal window here